Cell therapy
Showing 51 - 75 of >10,000
Heart Failure Trial in Copenhagen Ø (Cardiology Stem Cell Centre Adipose Stem Cell (CSCC_ASC), Placebo)
Completed
- Heart Failure
- Cardiology Stem Cell Centre Adipose Stem Cell (CSCC_ASC)
- Placebo
-
Copenhagen Ø, DenmarkCardiac Catheterization Laboratory 2014, The Heart Centre, Unive
Sep 2, 2022
Febrile Neutropenia Trial in Charleston (IDION iTempShield)
Not yet recruiting
- Febrile Neutropenia
- IDION iTempShield
-
Charleston, South CarolinaMedical University of South Carolina
Oct 8, 2022
A Long-Term Follow-Up Study of Participants Exposed to REACT
Not yet recruiting
- Diabetic Kidney Disease
- Chronic Kidney Diseases
- Renal Autologous Cell Therapy (REACT)
- (no location specified)
Jun 15, 2023
Langerhans Cell Histiocytosis Trial in Beijing (CD207 CAR-T cells)
Not yet recruiting
- Langerhans Cell Histiocytosis
- CD207 CAR-T cells
-
Beijing, ChinaBeijing Friendship Hospital, Capital Medical University
Jul 25, 2022
Acute Lymphoblastic Leukemia, Lymphoma, Multiple Myeloma Trial in Taiyuan (CAR-T Autologous T cell injection)
Recruiting
- Acute Lymphoblastic Leukemia
- +2 more
- CAR-T Autologous T cell injection
-
Taiyuan, Shanxi, ChinaShanxi Bethune Hospital
Dec 2, 2022
Muscle Stem Cell Quality in Atrophy
Not yet recruiting
- Muscle Weakness
- +5 more
- In vitro analyse
- (no location specified)
Oct 5, 2023
Aggressive Non-Hodgkin Lymphoma, Indolent Non-Hodgkin Lymphoma, Recurrent DLBCL Trial in Rochester (procedure, biological,
Active, not recruiting
- Aggressive Non-Hodgkin Lymphoma
- +9 more
- Cryosurgery
- +5 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Aug 9, 2022
Progressive Multifocal Leukoencephalopathy Trial (CE-VST01-JC)
Not yet recruiting
- Progressive Multifocal Leukoencephalopathy
- CE-VST01-JC
- (no location specified)
Sep 14, 2022
Lymphoma, Leukemia, Plasma Cell Dyscrasia Trial in San Francisco (Web Application)
Not yet recruiting
- Lymphoma
- +2 more
- Web Application
-
San Francisco, CaliforniaUniversity of California, San Francisco
Oct 4, 2022
Patients Who Received Gene-Modified Cell Therapy
Enrolling by invitation
- Long-term Follow-up
- Gene-Modified Cell Therapy
-
Philadelphia, PennsylvaniaAbramson Cancer Center Clinical Research Unit, University of Pen
Jul 21, 2022
Multiple Sclerosis, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive Trial in Palo Alto
Not yet recruiting
- Multiple Sclerosis
- +2 more
- KYV-101 anti-CD19 CAR-T cell therapy
- Standard lymphodepletion regimen
-
Palo Alto, CaliforniaStanford Multiple Sclerosis Center
Nov 13, 2023
Anal Fistula Trial in New York (E-CEL UVEC)
Recruiting
- Anal Fistula
- E-CEL UVEC
-
New York, New YorkWeill Cornell Medical College - NewYork-Presbyterian Hospital
Jan 18, 2023
Lupus Nephritis, Lupus Nephritis - World Health Organization (WHO) Class III, Lupus Nephritis - WHO Class IV Trial in Denver,
Recruiting
- Lupus Nephritis
- +2 more
- KYV-101 anti-CD19 CAR-T cell therapy
- Standard lymphodepletion regimen
-
Denver, Colorado
- +1 more
Jul 7, 2023
Cytomegalovirus Infections, Hematopoietic Stem Cell Transplant, Opportunistic Infections Trial in Cleveland (CMV specific
Recruiting
- Cytomegalovirus Infections
- +2 more
- CMV specific adoptive t-cells
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
Jul 26, 2022
Extramedullary Myeloma Trial in Melbourne (Combination Product: JNJ-68284528 (Cilta-cel) & 64Cu SPION dual PET-MR imaging agent)
Not yet recruiting
- Extramedullary Myeloma
- Combination Product: JNJ-68284528 (Cilta-cel) & 64Cu SPION dual PET-MR imaging agent
-
Melbourne, Victoria, AustraliaPeter MacCallum Cancer Centre
Dec 18, 2022
Soft Tissue Sarcoma, Bone Sarcoma Trial in Houston (Cyclophosphamide, attIL2-T cells)
Not yet recruiting
- Soft Tissue Sarcoma
- Bone Sarcoma
- Cyclophosphamide
- attIL2-T cells
-
Houston, TexasM D Anderson Cancer Center
Nov 10, 2022
T Lymphoblastic Leukemia/Lymphoma, T-cell Acute Lymphoblastic Leukemia, Peripheral T Cell Lymphoma Trial in Shanghai (anti-CD7
Recruiting
- T Lymphoblastic Leukemia/Lymphoma
- +4 more
- anti-CD7 CAR-T cells
-
Shanghai, ChinaXianmin General Song
Aug 29, 2022
Advanced Hepatocellular Carcinoma Trial (EU307 CAR-T Cell)
Not yet recruiting
- Advanced Hepatocellular Carcinoma
- EU307 CAR-T Cell
- (no location specified)
Mar 13, 2023
Brain Gliomas Trial in Suzhou (Allogenic B7H3 CAR-?dT cell)
Recruiting
- Brain Gliomas
- Allogenic B7H3 CAR-γδT cell
-
Suzhou, Jiangsu, ChinaDushu Lake Hospital Affiliated to Soochow University
Aug 25, 2023
Large B-cell Lymphoma, Diffuse Large B-cell Lymphoma Trial in Nashville (Telemedicine Visit, Vital sign measurements,
Recruiting
- Large B-cell Lymphoma
- Diffuse Large B-cell Lymphoma
- Telemedicine Visit
- +3 more
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
Sep 28, 2022
Large B-cell Lymphoma Trial in Groningen (89Zr-atezolizumab PET-imaging)
Recruiting
- Large B-cell Lymphoma
- 89Zr-atezolizumab PET-imaging
-
Groningen, NetherlandsUniversity Medical Center Groningen
Jul 15, 2022
Hepatocellular Carcinoma, Liver Cancer, Adult, Liver Tumor Trial in Duarte (ECT204 T cells)
Recruiting
- Hepatocellular Carcinoma
- +3 more
- ECT204 T cells
-
Duarte, California
- +1 more
Jan 9, 2023
Multiple Myeloma, Plasma Cell Tumor, Malignant Plasma Cell Tumor Trial in Houston (Radiation Therapy)
Recruiting
- Multiple Myeloma
- +2 more
- Radiation Therapy
-
Houston, TexasM D Anderson Cancer Center
Jul 9, 2022
Idiopathic Pulmonary Fibrosis Trial in Beijing, Shanghai (REGEND001, Placebo)
Recruiting
- Idiopathic Pulmonary Fibrosis
- REGEND001
- Placebo
-
Beijing, Beijing, China
- +2 more
Oct 7, 2023